Christopher Murphy

Finanzdirektor/CFO bei THIRD HARMONIC BIO, INC.

40 Jahre

Health Technology

Consumer Services

Ursprung des Netzwerks ersten Grades von Christopher Murphy

Einheit	Art der Einheit	Industrie
THIRD HARMONIC BIO, INC. 9	Public Company	Pharmaceuticals: Major	9

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von Christopher Murphy

Unternehmen	Sektor	Verknüpfte Personen	Hauptposition
SUMITOMO PHARMA CO., LTD.	Pharmaceuticals: Major	Mark Iwicki	Chief Executive Officer
Genentech, Inc. Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.	Biotechnology	Natalie Holles Edward Conner	Corporate Officer/Principal Chief Tech/Sci/R&D Officer
MERCK & CO., INC.	Pharmaceuticals: Major	Mark Iwicki	Corporate Officer/Principal
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.	Pharmaceuticals: Major	Mark Iwicki	Chief Executive Officer
BIOMARIN PHARMACEUTICAL INC.	Biotechnology	Edward Conner	Chief Tech/Sci/R&D Officer
SANGAMO THERAPEUTICS, INC.	Biotechnology	Edward Conner Julie Person	Chief Tech/Sci/R&D Officer Human Resources Officer
Pulmatrix Operating Co., Inc. Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA.	Pharmaceuticals: Major	Mark Iwicki	Director/Board Member
SHIRE	Pharmaceuticals: Major	Julie Person	Human Resources Officer
TARIS BioMedical LLC TARIS BioMedical LLC Pharmaceuticals: MajorHealth Technology TARIS BioMedical LLC operates as a clinical-stage pharmaceutical company. It specializes in urology, continuous local dosing, bladder diseases, oncology, voiding dysfunction. The company was founded by Robert S. Langer Jr., Christine Bunt, and Michael J. Cima in 2008 and is headquartered in Lexington, MA.	Pharmaceuticals: Major	Mark Iwicki	Director/Board Member
KALA BIO, INC.	Pharmaceuticals: Major	Mark Iwicki	Chief Executive Officer
Nimbus Therapeutics LLC Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA.	Biotechnology	Mark Iwicki	Director/Board Member
ULTRAGENYX PHARMACEUTICAL INC.	Pharmaceuticals: Major	Edward Conner	Corporate Officer/Principal
Oxeia Biopharmaceuticals, Inc. Oxeia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oxeia Biopharmaceuticals, Inc. is a clinical-stage biotech company, which develops new, innovative therapies for conditions that are defined by deficits in neurocognition from injury, degeneration and aging. Its two indications are for (i) mild traumatic brain injury (?mTB?) known as concussion, and (ii) the cognitive decline, lethargy and ?brain-fog? associated with Covid-19 infection, known as Covid Longhauler syndrome (?Long Covid?). The company was founded in 2014 by Vishal Bansal, Amit Dilip Munshi & Kartik Kiran Shah and is headquartered in Boston, MA.	Pharmaceuticals: Major	Mark Iwicki	Director/Board Member
Duke University Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.	College/University	Edward Conner	Undergraduate Degree
Harvard University Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.	College/University	David Bonita H. Seidel	Undergraduate Degree Doctorate Degree
Novartis Pharmaceuticals UK Ltd. Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom.	Pharmaceuticals: Major	Mark Iwicki	Corporate Officer/Principal
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.	Investment Managers	Mark Iwicki H. Seidel Michael Gladstone	Consultant / Advisor Consultant / Advisor Private Equity Investor
Astra Merck, Inc. Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million.	Pharmaceuticals: Major	Mark Iwicki	Corporate Officer/Principal
Ball State University (Indiana)	College/University	Mark Iwicki	Undergraduate Degree
Loyola University Maryland, Inc.	College/University	Mark Iwicki	Masters Business Admin
The University of California, San Francisco	College/University	Edward Conner	Doctorate Degree
Novartis Pharmaceuticals Corp. Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.	Pharmaceuticals: Major	Mark Iwicki	Corporate Officer/Principal
MERUS N.V.	Biotechnology	Mark Iwicki	Director/Board Member
Civitas Therapeutics, Inc. Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY.	Biotechnology	Mark Iwicki	Chief Executive Officer
ALLAKOS INC.	Pharmaceuticals: Major	Natalie Holles	Director/Board Member
AUDENTES THERAPEUTICS, INC.	Biotechnology	Thomas Soloway Natalie Holles Edward Conner Julie Person	Director of Finance/CFO Chief Executive Officer Chief Tech/Sci/R&D Officer Human Resources Officer
AIMMUNE THERAPEUTICS, INC.	Pharmaceuticals: Major	Mark Iwicki	Director/Board Member
University of Colorado Boulder	College/University	Natalie Holles	Graduate Degree
PULMATRIX, INC.	Pharmaceuticals: Major	Mark Iwicki	Chairman
Atlas Venture Life Science Advisors LLC Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts.	Investment Managers	Michael Gladstone	Private Equity Investor
REPLIMUNE GROUP, INC.	Biotechnology	Michael Gladstone	Director/Board Member
RUBIUS THERAPEUTICS	Biotechnology	Natalie Holles	Director/Board Member
Nimbus Apollo, Inc. Nimbus Apollo, Inc. Pharmaceuticals: MajorHealth Technology Nimbus Apollo, Inc. provides drug discovery research services. The company is headquartered in Cambridge, MA.	Pharmaceuticals: Major	Mark Iwicki	Director/Board Member
IFM Therapeutics LLC IFM Therapeutics LLC Pharmaceuticals: MajorHealth Technology IFM Therapeutics LLC engages in the development and transformation of immunotherapy for patients with serious diseases. It focuses on developing small molecule drugs that target the innate immune system. The company was founded by Gary D. Glick, Luigi Franchi, Matthias Geyer, Eicke Latz, and Anthony W. Opipari, Jr. in 2015 and is headquartered in Boston, MA.	Pharmaceuticals: Major	H. Seidel Michael Gladstone	Chief Executive Officer Director/Board Member
Wellesley Youth Hockey Association Wellesley Youth Hockey Association Movies/EntertainmentConsumer Services Wellesley Youth Hockey Association is a sports organization that promotes ice hockey and values such as sportsmanship, teamwork, and respect for the rules of play. The association is based in Wellesley, Massachusetts. The association offers various programs for different age groups, including travel teams, mite programs, and goalie training. It also provides resources for coaches, officials, and parents.	Movies/Entertainment	Mark Iwicki	Director/Board Member
AKERO THERAPEUTICS, INC.	Pharmaceuticals: Major	Mark Iwicki Michael Gladstone	Chairman Director/Board Member
Locanabio, Inc. Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA.	Packaged Software	Edward Conner	Chief Tech/Sci/R&D Officer
Q32 Bio, Inc. Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA.	Biotechnology	Mark Iwicki Michael Gladstone	Chairman Founder
AEROVATE THERAPEUTICS, INC.	Biotechnology	Mark Iwicki	Director/Board Member
DOT Therapeutics-2, Inc. DOT Therapeutics-2, Inc. Pharmaceuticals: MajorHealth Technology DOT Therapeutics-2, Inc. develops new therapies that change the outcome for people of all ages living with cancer. The company was founded by Julie Grant and Samuel Blackman and is headquartered in South San Francisco, CA.	Pharmaceuticals: Major	Natalie Holles Michael Gladstone	Director/Board Member Director/Board Member
DAY ONE BIOPHARMACEUTICALS, INC.	Pharmaceuticals: Major	Natalie Holles Michael Gladstone	Director/Board Member Director/Board Member
Xilio Therapeutics LLC Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Xilio Therapeutics, Inc., Xilio Therapeutics LLC develops cancer biopharmaceuticals. The company is based in Waltham, MA. The CEO of the company is René Russo.	Pharmaceuticals: Major	Michael Gladstone	Director/Board Member
NEUMORA THERAPEUTICS, INC.	Pharmaceuticals: Major	Julie Person	Human Resources Officer
Pheon Therapeutics Ltd. Pheon Therapeutics Ltd. BiotechnologyHealth Technology Pheon Therapeutics Ltd. is an antibody drug conjugate (ADC) specialist that develops a pipeline of monotherapies for novel targets and/or with novel payloads. The company is based in Harpdenden, UK. The British company's lead program is a first-in-class ADC against a novel target that is highly expressed in solid tumors across a broad range of hard-to-treat cancer types. ADCs offer the potential to treat solid tumors and liquid cancers that have not responded to other treatments. The company was founded in 2015 by Paul Jackson. Cyrus D. Mozayeni has been the CEO of the company since 2023.	Biotechnology	Michael Gladstone	Director/Board Member
Diagonal Therapeutics, Inc. Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Diagonal Therapeutics, Inc. is a biotechnology company located in the US that develops drugs for oncology, immunology, and rare diseases.	Biotechnology	Michael Gladstone	Director/Board Member